As of 19 September 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of pneumococcal vaccines for the prevention of disease caused by Streptococcus pneumoniae in elderly adults 60 years old and above, including the following vaccine regimen: (1) pneumococcal conjugate vaccine 13 (PCV13) in sequence to pneumococcal polysaccharide continue reading : HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above
HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above
As of 19 September 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of pneumococcal vaccines for the prevention of disease caused by Streptococcus pneumoniae in elderly adults 60 years old and above, including the following vaccine regimen: (1) pneumococcal conjugate vaccine 13 (PCV13) in sequence to pneumococcal polysaccharide continue reading : HTA Council Preliminary Recommendation Pneumococcal Conjugate Vaccines (PCV) for elderly adults 60 years old and above
HTA Council Preliminary Recommendation on Tuberculosis Diagnostic Tests
As of 19 June 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of the following health technologies for possible government financing: These health technologies were reviewed against clinical practice guidelines (CPGs) [local and approved by the DOH, such as the DOH Omnibus Health Guidelines (OHG); and/or international, but locally continue reading : HTA Council Preliminary Recommendation on Tuberculosis Diagnostic Tests
HTA Council Preliminary Recommendation on Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diptheria, and pertussis for Grade 1 students (6-7 years old, Grade 7 students (11-12 years old) and pregnant women
Update as of 26 May 2025 : The public consultation and appeals period for the HTA Council Preliminary Recommendation on Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diphtheria, and pertussis for Grade 1 students (6-7 years old), Grade 7 students (11-12 years old) and pregnant women ended on 19 May 2025. Having received continue reading : HTA Council Preliminary Recommendation on Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diptheria, and pertussis for Grade 1 students (6-7 years old, Grade 7 students (11-12 years old) and pregnant women
HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children
Update as of 14 May 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children ended on 13 May 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final continue reading : HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children